share_log

Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate

Benzinga ·  Mar 26 04:29

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.56) by 76.79 percent. This is a 16.1 percent increase over losses of $(1.18) per share from the same period last year.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment